Neutrophil CD64 as a marker of infection in patients treated with tocilizumab

Mod Rheumatol. 2009;19(6):696-7. doi: 10.1007/s10165-009-0223-8.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid / immunology*
  • Arthritis, Rheumatoid / therapy
  • Biomarkers
  • Female
  • Humans
  • Infections / immunology*
  • Middle Aged
  • Neutrophils / immunology*
  • Receptors, IgG / immunology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Receptors, IgG
  • tocilizumab